Andrew Menzies-Gow
Overview
Explore the profile of Andrew Menzies-Gow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
3166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jackson D, Heaney L, Humbert M, Kent B, Shavit A, Hiljemark L, et al.
Immunotherapy
. 2025 Jan;
16(20-22):1175-1184.
PMID: 39780731
No abstract available.
2.
Gibson D, Branscombe N, Martin N, Menzies-Gow A, Jain P, Padgett K, et al.
Pharmacoecon Open
. 2024 Aug;
8(6):923-934.
PMID: 39196476
Background: Oral corticosteroids (OCS) are effective anti-inflammatory agents used across a range of conditions. However, substantial evidence associates their use with increased risks for adverse events (AEs), causing high burden...
3.
Tran T, Heatley H, Bourdin A, Menzies-Gow A, Jackson D, Maslova E, et al.
J Asthma Allergy
. 2024 Jun;
17:573-587.
PMID: 38919734
Purpose: Oral corticosteroid (OCS) use for asthma is associated with considerable healthcare resource utilization (HCRU) and costs. However, no study has investigated this in relation to patterns of intermittent OCS...
4.
Bourdin A, Chupp G, Jackson D, Cohen D, Emerath U, Shavit A, et al.
J Allergy Clin Immunol Pract
. 2024 Apr;
12(8):2074-2083.e4.
PMID: 38677588
Background: Benralizumab and mepolizumab are interleukin (IL)-5Rα/interleukin-5-targeted monoclonal antibodies indicated as add-on treatments for patients with uncontrolled severe eosinophilic asthma (SEA). Objective: To evaluate and compare the safety of benralizumab...
5.
Wilkinson A, Maslova E, Janson C, Radhakrishnan V, Quint J, Budgen N, et al.
Thorax
. 2024 Feb;
PMID: 38413192
Background: Poorly controlled asthma is associated with increased morbidity and healthcare resource utilisation (HCRU). Therefore, to quantify the environmental impact of asthma care, this retrospective, cohort, healthCARe-Based envirONmental cost of...
6.
Bourdin A, Brusselle G, Couillard S, Fajt M, Heaney L, Israel E, et al.
J Allergy Clin Immunol Pract
. 2024 Jan;
12(4):809-823.
PMID: 38280454
Severe asthma is associated with significant morbidity and mortality despite the maximal use of inhaled corticosteroids and additional controller medications, and has a high economic burden. Biologic therapies are recommended...
7.
Loewenthal L, Busby J, McDowell R, Brown T, Burhan H, Chaudhuri R, et al.
Thorax
. 2023 Dec;
79(5):403-411.
PMID: 38124220
Introduction: After puberty, females are more likely to develop asthma and in a more severe form than males. The associations between asthma and sex are complex with multiple intrinsic and...
8.
Jackson D, Heaney L, Humbert M, Kent B, Shavit A, Hiljemark L, et al.
Lancet
. 2023 Dec;
403(10423):271-281.
PMID: 38071986
Background: Stepwise intensification of inhaled corticosteroids (ICS) is routine for severe eosinophilic asthma, despite some poor responses to high-dose ICS. Dose reductions are recommended in patients responding to biologics, but...
9.
McDowell R, Heaney L, Brown T, Bunting B, Burhan H, Chaudhuri R, et al.
PLoS One
. 2023 Dec;
18(12):e0295493.
PMID: 38060586
Background: The Asthma Control Questionnaire (ACQ) is used to assess asthma symptom control. The relationship between the questionnaire items and symptom control has not been fully studied in severe asthmatic...
10.
Cushen B, Koh M, Tran T, Martin N, Murray R, Uthaman T, et al.
Pragmat Obs Res
. 2023 Oct;
14:127-147.
PMID: 37881411
Aim: The International Severe Asthma Registry (ISAR; http://isaregistries.org/) uses standardised variables to enable multi-country and adequately powered research in severe asthma. This study aims to look at the data countries...